Search results
Results From The WOW.Com Content Network
According to a presentation by Dr. Steven Curley, essentially all forms of cancer are potentially treatable using Kanzius RF therapy. [12] Kanzius built a prototype Kanzius RF device in his home, and formed Therm Med, LLC to test and market his inventions. [13] [14] The device was tested at University of Pittsburgh Medical Center in 2005. [3]
On Tuesday, the FDA approved NovoCure’s (NASDAQ:NVCR) Optune Lua for concurrent use with PD-1/PD-L1 inhibitors or docetaxel for adult patients with metastatic non-small cell lung cancer (mNSCLC ...
(Reuters) -Novocure Ltd's experimental device to treat a type of lung cancer helped in extending overall survival among patients in a late-stage study, but concerns around its commercial success ...
The therapy, which uses a device, slowed the spread of cancer in the brain to 21.9 months, along with supportive care, compared to 11.3 months for supportive care alone in patients with non-small ...
A clinical TTFields device is manufactured by Novocure under the trade name Optune (formerly NovoTTF-100A), and is approved in the United States, Japan, Israel and multiple countries in Europe for the treatment of recurrent glioblastoma. These devices generate electromagnetic waves between 100 and 300 kHz. The devices can be used in conjunction ...
Oxygen therapy, also referred to as supplemental oxygen, is the use of oxygen as medical treatment. [1] Supplemental oxygen can also refer to the use of oxygen enriched air at altitude. Acute indications for therapy include hypoxemia (low blood oxygen levels), carbon monoxide toxicity and cluster headache .
According to the American Cancer Society, alternative approaches—such as chromotherapy or the use of light boxes—have not been shown to be effective for cancer treatment. [36] Magnetic therapy – the practice of placing magnets on and around the body in order to treat illness. Although this has been promoted as a treatment for cancer and ...
The combination therapy on Monday showed an overall survival rate of 12.2 months, not significantly higher than the 11.9 months in patients who were treated only with paclitaxel - the chemotherapy ...